Related Experiment Video

Updated: May 8, 2026

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

A novel colon cancer gene therapy using rAAV‑mediated expression of human shRNA-FHL2

Yao Wu1, Zheng Guo, Di Zhang

  • 1Guangdong Provincial Key Laboratory of Gastroenterology, Department of Digestive Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, P.R. China.

International Journal of Oncology
|September 7, 2013
PubMed

Insights

Suppression of Four and a half LIM-only protein 2 (FHL2) via recombinant adeno-associated virus (rAAV) halts colon cancer cell growth and induces apoptosis. This approach shows significant anti-tumor effects, enhanced with 5-FU, suggesting a novel colon cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Four and a half LIM-only protein 2 (FHL2) is an oncogene in colon cancer.
  • FHL2 suppression promotes colon cancer cell differentiation and tumorigenesis.
  • Targeting FHL2 offers a potential therapeutic strategy for colon cancer.

Purpose of the Study:

  • To develop an effective method for FHL2 knockdown using recombinant adeno-associated virus (rAAV) carrying FHL2-shRNA.
  • To investigate the effects of FHL2 suppression on colon cancer cell cycle, growth, and apoptosis.
  • To evaluate the therapeutic potential of rAAV-FHL2-shRNA, alone and in combination with 5-FU, in preclinical models.

Main Methods:

  • Generation of rAAV vectors expressing FHL2-shRNA.
  • Transfection of LoVo colon cancer cells with rAAV-FHL2-shRNA.
  • Assessment of cell cycle and growth using flow cytometry and WST-1 assay.
  • Western blot analysis of apoptosis-related proteins.
  • Establishment of a colon cancer xenograft model in nude mice.

Main Results:

  • rAAV-mediated FHL2 suppression induced G0/G1 cell cycle arrest and inhibited cell proliferation.
  • FHL2 knockdown activated both intrinsic and extrinsic apoptotic pathways.
  • Colon cancer cells exhibited increased sensitivity to 5-FU-induced apoptosis upon FHL2 suppression.
  • rAAV-FHL2-shRNA demonstrated significant anti-tumorigenic effects in vivo, which were potentiated by 5-FU co-treatment.

Conclusions:

  • FHL2 acts as a modulator of cell cycle and growth, inhibiting apoptosis in colon cancer.
  • rAAV-shRNA-FHL2 is a potent agent for colon cancer therapy.
  • Combination therapy with rAAV-shRNA-FHL2 and 5-FU enhances anti-tumor efficacy.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...